Integral Ad Science (NASDAQ:IAS) Price Target Raised to $17.00

Integral Ad Science (NASDAQ:IAS - Get Free Report) had its price objective lifted by investment analysts at Truist Financial from $16.00 to $17.00 in a research note issued on Monday,Benzinga reports. The firm presently has a "buy" rating on the stock. Truist Financial's price objective points to a potential upside of 68.15% from the company's current price.

IAS has been the topic of several other research reports. Benchmark reissued a "hold" rating on shares of Integral Ad Science in a report on Friday, February 28th. Piper Sandler cut their target price on Integral Ad Science from $18.00 to $16.00 and set an "overweight" rating on the stock in a research report on Wednesday, November 13th. Craig Hallum dropped their price target on shares of Integral Ad Science from $18.00 to $16.00 and set a "buy" rating on the stock in a research note on Wednesday, November 13th. Barclays restated an "equal weight" rating on shares of Integral Ad Science in a research report on Friday, February 28th. Finally, Scotiabank assumed coverage on shares of Integral Ad Science in a research report on Friday, February 28th. They issued a "sector perform" rating and a $12.00 target price on the stock. Four equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $15.06.

Remove Ads

Integral Ad Science Trading Down 1.4 %

Shares of IAS traded down $0.14 during midday trading on Monday, reaching $10.11. The company had a trading volume of 1,552,240 shares, compared to its average volume of 938,589. The company has a quick ratio of 3.71, a current ratio of 3.71 and a debt-to-equity ratio of 0.07. The firm has a 50 day simple moving average of $10.34 and a 200-day simple moving average of $10.81. Integral Ad Science has a 1-year low of $7.98 and a 1-year high of $13.62. The stock has a market cap of $1.64 billion, a PE ratio of 50.55, a price-to-earnings-growth ratio of 1.06 and a beta of 1.46.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last released its quarterly earnings results on Friday, February 28th. The company reported $0.09 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.12 by ($0.03). The company had revenue of $153.00 million during the quarter, compared to analysts' expectations of $148.83 million. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. Integral Ad Science's revenue was up 13.9% on a year-over-year basis. During the same period last year, the firm posted $0.06 earnings per share. Research analysts forecast that Integral Ad Science will post 0.26 EPS for the current fiscal year.

Insider Buying and Selling at Integral Ad Science

In other news, CEO Lisa Utzschneider sold 5,940 shares of the firm's stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $9.75, for a total value of $57,915.00. Following the completion of the sale, the chief executive officer now owns 266,926 shares in the company, valued at approximately $2,602,528.50. This trade represents a 2.18 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In the last ninety days, insiders have sold 19,109 shares of company stock worth $197,696. 2.00% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Integral Ad Science

A number of institutional investors have recently added to or reduced their stakes in IAS. Alyeska Investment Group L.P. purchased a new position in Integral Ad Science in the fourth quarter worth $41,543,000. Dimensional Fund Advisors LP lifted its stake in shares of Integral Ad Science by 18.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,789,996 shares of the company's stock valued at $39,567,000 after purchasing an additional 580,323 shares during the period. Clearline Capital LP purchased a new stake in Integral Ad Science during the fourth quarter worth about $3,949,000. Invenomic Capital Management LP grew its position in Integral Ad Science by 52.9% during the fourth quarter. Invenomic Capital Management LP now owns 895,061 shares of the company's stock worth $9,344,000 after buying an additional 309,752 shares during the period. Finally, Ararat Capital Management LP grew its position in Integral Ad Science by 13.4% during the fourth quarter. Ararat Capital Management LP now owns 2,281,912 shares of the company's stock worth $23,823,000 after buying an additional 269,346 shares during the period. Hedge funds and other institutional investors own 95.78% of the company's stock.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.